Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Obesity and Serious Mental Ill Health: A Critical Review of the Literature.

Bradshaw T, Mairs H.

Healthcare (Basel). 2014 Apr 1;2(2):166-82. doi: 10.3390/healthcare2020166. Review.

2.

Cancer screening, prevention, and treatment in people with mental illness.

Weinstein LC, Stefancic A, Cunningham AT, Hurley KE, Cabassa LJ, Wender RC.

CA Cancer J Clin. 2016 Mar-Apr;66(2):134-51. doi: 10.3322/caac.21334. Epub 2015 Dec 10.

3.

The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysis.

Bruins J, Jörg F, Bruggeman R, Slooff C, Corpeleijn E, Pijnenborg M.

PLoS One. 2014 Dec 4;9(12):e112276. doi: 10.1371/journal.pone.0112276. eCollection 2014.

4.

A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept.

Tek C, Ratliff J, Reutenauer E, Ganguli R, O'Malley SS.

J Clin Psychopharmacol. 2014 Oct;34(5):608-12. doi: 10.1097/JCP.0000000000000192.

6.

Les recommandations de prise en charge des complications métaboliques associées aux antipsychotiques de deuxième génération chez les enfants et les adolescents.

Ho J, Panagiotopoulos C, McCrindle B, Grisaru S, Pringsheim T.

Paediatr Child Health. 2012 Oct;17(Suppl B):5B-11B. French.

7.

Interventions for the metabolic syndrome in schizophrenia: a review.

Papanastasiou E.

Ther Adv Endocrinol Metab. 2012 Oct;3(5):141-62. doi: 10.1177/2042018812458697.

8.

Management recommendations for metabolic complications associated with second-generation antipsychotic use in children and youth.

Ho J, Panagiotopoulos C, McCrindle B, Grisaru S, Pringsheim T; Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) guideline group.

Paediatr Child Health. 2011 Nov;16(9):575-80.

9.

Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients.

Mitchell AJ, Vancampfort D, De Herdt A, Yu W, De Hert M.

Schizophr Bull. 2013 Mar;39(2):295-305. doi: 10.1093/schbul/sbs082. Epub 2012 Aug 27. Review.

10.

Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials.

Bonfioli E, Berti L, Goss C, Muraro F, Burti L.

BMC Psychiatry. 2012 Jul 12;12:78. doi: 10.1186/1471-244X-12-78. Review.

11.

Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: results from a 12-month, real-world study.

Zhang JP, Weiss JJ, McCardle M, Klopchin H, Rosendahl E, Maayan L, Convit A, Kane JM, Manu P, Correll CU.

J Clin Psychopharmacol. 2012 Aug;32(4):458-64. doi: 10.1097/JCP.0b013e31825cccd2.

12.

Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers.

Fiedorowicz JG, Miller DD, Bishop JR, Calarge CA, Ellingrod VL, Haynes WG.

Curr Psychiatry Rev. 2012 Feb 1;8(1):25-36.

13.

Management recommendations for metabolic complications associated with second generation antipsychotic use in children and youth.

Ho J, Panagiotopoulos C, McCrindle B, Grisaru S, Pringsheim T; CAMESA guideline group.

J Can Acad Child Adolesc Psychiatry. 2011 Aug;20(3):234-41.

14.

Antipsychotic medication for early episode schizophrenia.

Bola J, Kao D, Soydan H.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD006374. doi: 10.1002/14651858.CD006374.pub2. Review.

15.

Early intervention for psychosis.

Marshall M, Rathbone J.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD004718. doi: 10.1002/14651858.CD004718.pub3. Review.

16.

A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report.

Goldstein TR, Goldstein BI, Mantz MB, Bailey B, Douaihy A.

J Child Adolesc Psychopharmacol. 2011 Jun;21(3):275-80. doi: 10.1089/cap.2010.0104.

17.

Using internet enabled mobile devices and social networking technologies to promote exercise as an intervention for young first episode psychosis patients.

Killackey E, Anda AL, Gibbs M, Alvarez-Jimenez M, Thompson A, Sun P, Baksheev GN.

BMC Psychiatry. 2011 May 12;11:80. doi: 10.1186/1471-244X-11-80.

18.

Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review.

Verhaeghe N, De Maeseneer J, Maes L, Van Heeringen C, Annemans L.

Int J Behav Nutr Phys Act. 2011 Apr 11;8:28. doi: 10.1186/1479-5868-8-28. Review.

19.

Metabolic effects of olanzapine in patients with newly diagnosed psychosis.

Fernandez-Egea E, Miller B, Garcia-Rizo C, Bernardo M, Kirkpatrick B.

J Clin Psychopharmacol. 2011 Apr;31(2):154-9. doi: 10.1097/JCP.0b013e31820fcea3.

20.

Effects of a multimodal lifestyle intervention on body mass index in patients with bipolar disorder: a randomized controlled trial.

Gillhoff K, Gaab J, Emini L, Maroni C, Tholuck J, Greil W.

Prim Care Companion J Clin Psychiatry. 2010;12(5). pii: PCC.09m00906. doi: 10.4088/PCC.09m00906yel.

Items per page

Supplemental Content

Write to the Help Desk